Healthcare costs were found to be more than eight times higher for people with pulmonary arterial hypertension (PAH) compared…
Articles by Andrea Lobo
Gemcitabine, a chemotherapy given to treat solid cancers, may drive the onset of pulmonary arterial hypertension (PAH) in patients…
Treatment with Revatio (sildenafil) at a higher dose than the recommended and previously approved doses did not significantly increase…
Levels of fractional exhaled nitric oxide (FeNO) — a measure of how much nitric oxide a person exhales — may…
Findings of a new study into pericytes — cells with multiple functions including immune cell regulation — suggest that targeting…
The U.S. Food and Drug Administration (FDA) has supported Inhibikase Therapeutics’ Phase 2/3 trial of its experimental formulation of…
Chiesi Group has reached an agreement with Gossamer Bio to develop and market seralutinib for certain types of…
A diet poor in two amino acids called glutamine and serine may improve the health of pulmonary blood vessels and…
Low levels of PM20D1, a molecule involved in metabolizing lipids, were identified as a risk factor for mortality in people…
Two genes were identified as potential drivers of pulmonary arterial hypertension (PAH) in people with HIV-1 infection in a…
Low levels of circular RNA Alstrom syndrome protein 1, or circALMS1, may be associated with poor outcomes with pulmonary…
Most people with pulmonary arterial hypertension (PAH) due to connective tissue disease (CTD) who are using Opsumit (macitenan)…